Professional Summary
Professional Overview
Sean Sullivan is the Vice President Head of Technology Innovation at Arcturus Therapeutics, a leading biopharmaceutical company focused on developing innovative RNA medicines. With over 30 years of experience in the pharmaceutical and biotechnology industries, Sean is a seasoned research and development leader, known for his expertise in pharmaceutical sciences, process development, and technology innovation.
Experience Summary
Current Role
As Vice President Head of Technology Innovation at Arcturus Therapeutics, Sean is responsible for driving the company's technology roadmap and overseeing the development of cutting-edge RNA-based therapeutics. In this role, he leads a team of skilled scientists and engineers, guiding the implementation of innovative platforms and processes to advance Arcturus' pipeline of transformative therapies. Sean's technical expertise and strategic vision have been instrumental in accelerating the company's R&D efforts and positioning Arcturus as a leader in the field of RNA-based medicine.
Career Progression
Prior to his current role, Sean held senior-level positions at several prominent pharmaceutical and biotechnology organizations. As the Senior Executive Director of Pharmaceutical Sciences and Process Development at Vical, he played a pivotal role in the development and scale-up of numerous DNA-based vaccine and therapeutic candidates. Earlier in his career, Sean served as an Associate Professor at the University of Florida College of Pharmacy, where he conducted extensive research in the areas of gene delivery and nanomedicine. He has also held scientific leadership roles at companies such as Valentis/Genemedicine, Ribozyme Pharmaceuticals/SIRNA/Merck, and Vestar/Nexstar/Gilead.
Academic Background
Sean holds a Ph.D. in Pharmaceutical Chemistry from the California Institute of Technology, where he focused his research on the development of novel drug delivery systems and the application of nanotechnology in biomedicine. His technical expertise and academic achievements have been widely recognized, with numerous peer-reviewed publications and invited presentations at industry-leading conferences.
Areas of Expertise
- Pharmaceutical sciences and process development
- RNA-based therapeutics and gene delivery platforms
- Nanomedicine and drug delivery systems
- Biopharmaceutical research and development
- Technical leadership and team management
- Strategic planning and innovation
Professional Impact
Throughout his career, Sean has made significant contributions to the advancement of pharmaceutical and biotechnology research. His work has led to the successful development and commercialization of several DNA-based vaccine and therapeutic products, and his current focus on RNA-based medicines has the potential to transform the way we treat a wide range of diseases. Sean's innovative approach, coupled with his strong technical and managerial expertise, has earned him a reputation as a highly respected leader in the industry.
Conclusion
With his extensive experience, proven track record of success, and deep technical expertise, Sean Sullivan is well-positioned to continue driving transformative advancements in the field of RNA-based therapeutics. As the Vice President Head of Technology Innovation at Arcturus Therapeutics, he is poised to play a pivotal role in shaping the future of the company and the broader biopharmaceutical industry.
